Trellus Health plc has signed an agreement with a large US health plan, focused on Inflammatory Bowel Disease condition management. The agreement is intended to run for up to twenty-one (21) months, during which time members of the health plan with IBD that are receiving care in two US states will be eligible for inclusion in the Trellus Elevatetm IBD program.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 GBX | +8.57% | -5.00% | -41.54% |
Apr. 24 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
Apr. 23 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.54% | 3.82M | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
-24.56% | 46.55B | |
+31.16% | 50.15B | |
+17.75% | 41.41B | |
+55.21% | 35.63B | |
-10.24% | 24.64B | |
-21.24% | 23.04B |
- Stock Market
- Equities
- TRLS Stock
- News Trellus Health plc
- Trellus Health plc Announces Agreement with US Health Plan